The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

KAMPALA, KAMPALA | Xinhua | Uganda on Saturday launched mpox vaccination campaign targeting high-risk populations in Kampala, ...

If authorised, Vimkunya would be the first vaccine in the EU to protect adolescents aged 12 to 17 against Chikungunya.

Ugandan health officials on Thursday confirmed a case of Ebola in the capital Kampala, in a nurse who sought care at a number ...

There is a new and exciting buzz at Beugelsdijk Chiropractic that is making a noticeable impact for many trying to manage ...

A scientific team looks at the progress and challenges in the research and development of brain implants. New achievements in the field of this technology are seen as a source of hope for many ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Introduction During the first wave of the COVID-19 outbreak in China, the surge of COVID-19 cases was rapid and drastic. Emerging evidence suggests that beyond the acute phase, patients with COVID-19 ...

Saint-Herblain (France), January 22, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced positive results for its Phase 2 clinical trial evaluating the safety and ... severe joint ...

including the potential of CG001419 to reduce the risk of addiction associated with other pharmaceutical therapies for the treatment of pain; the study design for the Phase 1 healthy volunteer ...

Investopedia / Michela Buttignol The financial markets can seem utterly unpredictable but, in reality, they move in four distinct phases. Understanding how each phase works makes the difference ...

While the details of the ceasefire and hostage release agreement are still hazy, Qatar Prime Minister Sheikh Mohammed bin Abdulrahman bin Jassim al-Thani said the first phase of the agreement will ...